<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2020-5.4.5</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-2390</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДИСКУССИОННЫЕ СТАТЬИ, ЛЕКЦИИ, НОВЫЕ ТРЕНДЫ МЕДИЦИНСКОЙ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DISCUSSION PAPERS, LECTURES, NEW TRENDS IN MEDICAL SCIENCE</subject></subj-group></article-categories><title-group><article-title>Митохондрии: старение, метаболический синдром и сердечно-сосудистая патология. Становление новой парадигмы</article-title><trans-title-group xml:lang="en"><trans-title>Mitochondria: Aging, Metabolic Syndrome and Cardiovascular Diseases. Formation of a New Paradigm</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8198-7780</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Panov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панов Александр Васильевич – доктор биологических наук, старший научный сотрудник лаборатории патофизиологии </p><p>664003, г. Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Alexander V. Panov – Dr. Sc. (Biol.), Leading Research Officer at the Department of Pathophysiology </p><p>Timiryaseva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">alexander.panov55@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2976-6184</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дикалов</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Dikalov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дикалов Сергей Иванович – доцент, директор лаборатории свободных радикалов в медицине отдела клинической фармакологии, Департамент медицины </p><p>37232, Нэшвилл, Теннесси, Пирс Авеню 2220</p></bio><bio xml:lang="en"><p>Sergey I. Dikalov – Associate Professor of Medicine, Director of Free Radicals in Medicine Core</p><p>2220 Pierce Ave, Nashiville, TN, 37232</p></bio><email xlink:type="simple">sergey.dikalov@vanderbilt.edu</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3255-2013</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даренская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Darenskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Даренская Марина Александровна – доктор биологических наук, ведущий научный сотрудник лаборатории патофизиологии </p><p>664003, г. Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Marina A. Darenskaya – Dr. Sc. (Biol.), Leading Research Officer at the Department of Pathophysiology </p><p>Timiryaseva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0117-2563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рычкова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rychkova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рычкова Любовь Владимировна – доктор медицинских наук, профессор РАН, член-корреспондент РАН, директор </p><p>664003, г. Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Lyubov V. Rychkova – Dr. Sc. (Med.), Professor of the Russian Academy of Sciences, Corresponding Member of the Russian Academy of Sciences, Director </p><p>Timiryaseva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3354-2992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесникова Любовь Ильинична – академик РАН, научный руководитель </p><p>664003, г. Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Lyubov I. Kolesnikova – Academician of the Russian Academy of Sciences, Scientific Supervisor </p><p>Timiryaseva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2124-6328</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесников</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikov</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колесников Сергей Иванович – академик РАН, главный научный сотрудник </p><p>664003, г. Иркутск, ул. Тимирязева, 16</p></bio><bio xml:lang="en"><p>Sergey I. Kolesnikov – Academician of the Russian Academy of Sciences, Chief Research Officer </p><p>Timiryaseva str. 16, Irkutsk 664003</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научный центр проблем здоровья семьи и репродукции человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Family Health and Human Reproduction Problems</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медицинский центр Университета Вандербильта</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>Division of Clinical Pharmacology, Vanderbilt University Medical Center</institution><country>United States</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>07</day><month>09</month><year>2020</year></pub-date><volume>5</volume><issue>4</issue><fpage>33</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Панов А.В., Дикалов С.И., Даренская М.А., Рычкова Л.В., Колесникова Л.И., Колесников С.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Панов А.В., Дикалов С.И., Даренская М.А., Рычкова Л.В., Колесникова Л.И., Колесников С.И.</copyright-holder><copyright-holder xml:lang="en">Panov A.V., Dikalov S.I., Darenskaya M.A., Rychkova L.V., Kolesnikova L.I., Kolesnikov S.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/2390">https://www.actabiomedica.ru/jour/article/view/2390</self-uri><abstract><p>Сердечно-сосудистые патологии являются одними из главных причин смертности пожилых людей в развитых странах. Окислительный стресс, который вызывает мутации митохондриальной ДНК и дисфункции митохондрий, рассматривается как основная причина патологии сердца и других болезней старости. Однако в последние годы прежние парадигмы механизмов старения, окислительного стресса и антиоксидантной защиты подверглись сомнению и в некоторых случаях даже оказались ошибочными. В этом обзоре мы обсуждаем новые данные, которые привели к необходимости пересмотра парадигм. Мы показываем, что, хотя митохондриальная свободно-радикальная теория остаётся верной, радикалом, ответственным за старение, является протонированная форма супероксидного радикала, а именно пергидроксильный радикал, который игнорировался все предыдущие годы. Пергидроксильный радикал инициирует изопростановый путь перекисного окисления (ИППОЛ) полиненасыщенных жирных кислот, которые являются частью фосфолипидов мембраны митохондрий. ИППОЛ был открыт 30 лет назад Робертсом и Морроу в Университете Вандербильта, но механизм его инициации оставался неизвестным. ИППОЛ вызывает образование рацемической смеси сотен биологически активных молекул, названных изопростаны, и очень токсичных молекул, прежде всего изолевугландинов. Мы различаем два типа повреждений, вызванных ИППОЛ в ходе старения. Первый тип связан с окислительным повреждением кардиолипина и фосфатидилэтанаоламина (ФЭА), которые приводят к нарушениям структуры и функций полиферментных комплексов системы окислительного фосфорилирования. Второй тип дисфункций связан с прямым действием продуктов ИППОЛ на лизин-содержащие белки и ФЭА. К этому типу митохондриальных повреждений очевидно принадлежит окислительное повреждение митохондриальной ДНК полимеразы, что приводит к 20-кратному увеличению мутаций мтДНК.</p></abstract><trans-abstract xml:lang="en"><p>Cardiovascular diseases are among the major causes of mortality among aged people in most developed countries. Oxidative stress, which causes mutations of mitochondrial DNA and mitochondrial dysfunctions, was considered as the main mechanism of heart failure and other pathologies of old age. However, in recent years the prior paradigm of mechanisms of aging, oxidative stress and antioxidative defense was questioned and in some aspects even turned out to be wrong. In this review, we discuss the new data that led to the need to reconsider paradigms. We show that although the mitochondrial free radical theory of aging remains valid, the radical responsible for the aging is the protonated form of the superoxide radical, namely perhydroxyl radical, which was largely ignored all previous years. Perhydroxyl radical initiates the isoprostane pathway of lipid peroxidation (IPLP) of polyunsaturated fatty acids, which are part of the phospholipid core of the mitochondrial inner membrane. IPLP was discovered 30 years ago by Roberts and Morrow at the Vanderbilt University, but the mechanism of its initiation remained unknown. The IPLP causes formation of the racemic mixture of hundreds of biologically active products, named isoprostanes, and highly toxic molecules, first of all isolevuglandins. We distinguish two types of damages caused by IPLP during aging. The first one is associated with oxidative damages to cardiolipin and phosphatidylethanolamine (PEA), which result in disruption of polyenzymatic complexes of the oxidative phosphorylation system. The second type of dysfunctions is caused by the direct actions of toxic products on the lysine-containing proteins and PEA. To this type of mitochondrial damages evidently belongs the oxidative damage of the mitochondrial DNA polymerase, which results in a 20-fold increase in mutations of mitochondrial mtDNA.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>митохондрии</kwd><kwd>старение</kwd><kwd>метаболический синдром</kwd><kwd>окислительный стресс</kwd><kwd>кардиолипин</kwd><kwd>фосфатидилэтаноламин</kwd><kwd>изопростановое перекисное окисление липидов</kwd><kwd>изолевугландины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mitochondria</kwd><kwd>aging</kwd><kwd>metabolic syndrome</kwd><kwd>oxidative stress</kwd><kwd>cardiolipin</kwd><kwd>phosphatidylethanolamine</kwd><kwd>isoprostane lipid peroxidation</kwd><kwd>isolevuglandins</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6): 231-237. doi: 10.1242/dmm.001180</mixed-citation><mixed-citation xml:lang="en">Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6): 231-237. doi: 10.1242/dmm.001180</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92(2): 399-404. doi: 10.1210/jc.2006-0513</mixed-citation><mixed-citation xml:lang="en">Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92(2): 399-404. doi: 10.1210/jc.2006-0513</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002; 7(2): 115-130. doi: 10.1023/a:1015320423577</mixed-citation><mixed-citation xml:lang="en">Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002; 7(2): 115-130. doi: 10.1023/a:1015320423577</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schaper J, Meiser E, Stammler G. Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res. 1985; 56(3): 377-391. doi: 10.1161/01.RES.56.3.377</mixed-citation><mixed-citation xml:lang="en">Schaper J, Meiser E, Stammler G. Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res. 1985; 56(3): 377-391. doi: 10.1161/01.RES.56.3.377</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гурин А.М. Структурно-функциональные особенности сердечной мышечной ткани человека. Современные наукоёмкие технологии. 2009; 11(Прил.): 28-40.</mixed-citation><mixed-citation xml:lang="en">Gurin AM. Structural and functional features of the human cardiac muscle tissue. Sovremennye naukoemkie tekhnologii. 2009; 11(Suppl.): 28-40. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Opie LH, Lopaschuk GD. Fuels: aerobic and anaerobic metabolism. In: Opie LH (ed.) Heart Physiology: From Cell to Circulation. Philadelphia: Lippincott Williams &amp; Wilkins; 2004. 306-354.</mixed-citation><mixed-citation xml:lang="en">Opie LH, Lopaschuk GD. Fuels: aerobic and anaerobic metabolism. In: Opie LH (ed.) Heart Physiology: From Cell to Circulation. Philadelphia: Lippincott Williams &amp; Wilkins; 2004. 306-354.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rolfe DFS, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997; 77(3): 731-758. doi: 10.1152/physrev.1997.77.3.731</mixed-citation><mixed-citation xml:lang="en">Rolfe DFS, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev. 1997; 77(3): 731-758. doi: 10.1152/physrev.1997.77.3.731</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Freire M, de Cabo R, Bernier M, Sollott SJ, Fabbri E, Navas P, et al. Reconsidering the role of mitochondria in aging. J Gerontol A Biol Sci Med Sci. 2015; 70(11): 1334-1342. doi: 10.1093/gerona/glv070</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Freire M, de Cabo R, Bernier M, Sollott SJ, Fabbri E, Navas P, et al. Reconsidering the role of mitochondria in aging. J Gerontol A Biol Sci Med Sci. 2015; 70(11): 1334-1342. doi: 10.1093/gerona/glv070</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Panov AV. Synergistic oxidation of fatty acids, glucose and amino acids metabolites by isolated rat heart mitochondria. EC Cardiology. 2018; 5(4): 198-208.</mixed-citation><mixed-citation xml:lang="en">Panov AV. Synergistic oxidation of fatty acids, glucose and amino acids metabolites by isolated rat heart mitochondria. EC Cardiology. 2018; 5(4): 198-208.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Panov AV, Dikalov SI. The mitochondrial metabolism and the age-associated cardiovascular diseases. EC Cardiology. 2018; 5(11): 750-769.</mixed-citation><mixed-citation xml:lang="en">Panov AV, Dikalov SI. The mitochondrial metabolism and the age-associated cardiovascular diseases. EC Cardiology. 2018; 5(11): 750-769.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88(6): 2404-2411. doi: 10.1210/jc.2003-030242</mixed-citation><mixed-citation xml:lang="en">Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003; 88(6): 2404-2411. doi: 10.1210/jc.2003-030242</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92(2): 399-404. doi: 10.1210/jc.2006-0513</mixed-citation><mixed-citation xml:lang="en">Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 2007; 92(2): 399-404. doi: 10.1210/jc.2006-0513</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998; 78(2): 547-581. doi: 10.1152/physrev.1998.78.2.547</mixed-citation><mixed-citation xml:lang="en">Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998; 78(2): 547-581. doi: 10.1152/physrev.1998.78.2.547</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci. 2006; 1067(1): 10-21. doi: 10.1196/annals.1354.003</mixed-citation><mixed-citation xml:lang="en">Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci. 2006; 1067(1): 10-21. doi: 10.1196/annals.1354.003</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ryzhkova AI, Sazonova MA, Sinyov VV, Galitsyna EV, Chicheva MM, Melnichenko AA, et al. Mitochondrial diseases caused by mtDNA mutations: a mini-review. Ther Clin Risk Manag. 2018; 14: 1933-1942. doi: 10.2147/TCRM.S154863</mixed-citation><mixed-citation xml:lang="en">Ryzhkova AI, Sazonova MA, Sinyov VV, Galitsyna EV, Chicheva MM, Melnichenko AA, et al. Mitochondrial diseases caused by mtDNA mutations: a mini-review. Ther Clin Risk Manag. 2018; 14: 1933-1942. doi: 10.2147/TCRM.S154863</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Volobueva A, Grechko A, Yet S-F, Sobenin I, Orekhov A. Changes in mitochondrial genome associated with predisposition to atherosclerosis and related disease. Biomolecules. 2019; 9(8): 377. doi: 10.3390/biom9080377</mixed-citation><mixed-citation xml:lang="en">Volobueva A, Grechko A, Yet S-F, Sobenin I, Orekhov A. Changes in mitochondrial genome associated with predisposition to atherosclerosis and related disease. Biomolecules. 2019; 9(8): 377. doi: 10.3390/biom9080377</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Pinto M, Moraes CT. Mechanisms linking mtDNA damage and aging. Free Radic Biol Med. 2015; 85: 250-258. doi: 10.1016/j.freeradbiomed.2015.05.005</mixed-citation><mixed-citation xml:lang="en">Pinto M, Moraes CT. Mechanisms linking mtDNA damage and aging. Free Radic Biol Med. 2015; 85: 250-258. doi: 10.1016/j.freeradbiomed.2015.05.005</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Szczepanowska K, Trifunovic A. Origins of mtDNA mutations in ageing. Essays Biochem. 2017; 61(3): 325-337. doi: 10.1042/EBC20160090</mixed-citation><mixed-citation xml:lang="en">Szczepanowska K, Trifunovic A. Origins of mtDNA mutations in ageing. Essays Biochem. 2017; 61(3): 325-337. doi: 10.1042/EBC20160090</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">DeBalsi KL, Hoff KE, Copeland WC. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev. 2017; 33: 89-104. doi: 10.1016/j.arr.2016.04.006</mixed-citation><mixed-citation xml:lang="en">DeBalsi KL, Hoff KE, Copeland WC. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev. 2017; 33: 89-104. doi: 10.1016/j.arr.2016.04.006</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chocron ES, Munkácsya E, Pickering AM. Cause or casualty: The role of mitochondrial DNA in aging and age associated disease. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2): 285-297. doi: 10.1016/j.bbadis.2018.09.035</mixed-citation><mixed-citation xml:lang="en">Chocron ES, Munkácsya E, Pickering AM. Cause or casualty: The role of mitochondrial DNA in aging and age associated disease. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2): 285-297. doi: 10.1016/j.bbadis.2018.09.035</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009; 417(1): 1-13. doi: 10.1042/BJ20081386</mixed-citation><mixed-citation xml:lang="en">Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009; 417(1): 1-13. doi: 10.1042/BJ20081386</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Brand MD. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med. 2016; 100: 14-31. doi: 10.1016/j.freeradbiomed.2016.04.001</mixed-citation><mixed-citation xml:lang="en">Brand MD. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radic Biol Med. 2016; 100: 14-31. doi: 10.1016/j.freeradbiomed.2016.04.001</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sawyer DT, Valentine JS. How super is superoxide? Acc Chem Res. 1981; 14: 393-400. doi: 10.1021/ar00072a005</mixed-citation><mixed-citation xml:lang="en">Sawyer DT, Valentine JS. How super is superoxide? Acc Chem Res. 1981; 14: 393-400. doi: 10.1021/ar00072a005</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends. Endocrinol Metab. 2009; 20(8): 394-401. doi: 10.1016/j.tem.2009.04.004</mixed-citation><mixed-citation xml:lang="en">Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends. Endocrinol Metab. 2009; 20(8): 394-401. doi: 10.1016/j.tem.2009.04.004</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hernando-Rodriguez B, Artal-Sanz M. Mitochondrial quality control mechanisms and the PHB (prohibitin) complex. Cells. 2018; 7(12): 238. doi: 10.3390/cells7120238</mixed-citation><mixed-citation xml:lang="en">Hernando-Rodriguez B, Artal-Sanz M. Mitochondrial quality control mechanisms and the PHB (prohibitin) complex. Cells. 2018; 7(12): 238. doi: 10.3390/cells7120238</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsh T, Macho A. et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996; 184(3): 1155-1160. doi: 10.1084/jem.184.3.1155</mixed-citation><mixed-citation xml:lang="en">Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsh T, Macho A. et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996; 184(3): 1155- 1160. doi: 10.1084/jem.184.3.1155</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium. 2009; 45(6): 643-650. doi: 10.1016/j.ceca.2009.03.012</mixed-citation><mixed-citation xml:lang="en">Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium. 2009; 45(6): 643-650. doi: 10.1016/j.ceca.2009.03.012</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int. 2011; 58(4): 447-457. doi: 10.1016/j.neuint.2010.12.016</mixed-citation><mixed-citation xml:lang="en">Paradies G, Petrosillo G, Paradies V, Ruggiero FM. Mitochondrial dysfunction in brain aging: role of oxidative stress and cardiolipin. Neurochem Int. 2011; 58(4): 447-457. doi: 10.1016/j.neuint.2010.12.016</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Brame CJ, Boutaud O, Davies SS, Yang T, Oates JA, Roden D, et al. Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem. 2004; 279: 13447-13451. doi: 10.1074/jbc.M313349200</mixed-citation><mixed-citation xml:lang="en">Brame CJ, Boutaud O, Davies SS, Yang T, Oates JA, Roden D, et al. Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem. 2004; 279: 13447-13451. doi: 10.1074/jbc.M313349200</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990; 87(23): 9383-9387. doi: 10.1073/pnas.87.23.9383</mixed-citation><mixed-citation xml:lang="en">Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA. 1990; 87(23): 9383-9387. doi: 10.1073/pnas.87.23.9383</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Jouhet J. Importance of the hexagonal lipid phase in biological membrane organization. Front Plant Sci. 2013; 4: 494. doi: 10.3389/fpls.2013.00494</mixed-citation><mixed-citation xml:lang="en">Jouhet J. Importance of the hexagonal lipid phase in biological membrane organization. Front Plant Sci. 2013; 4: 494. doi: 10.3389/fpls.2013.00494</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Horvath SE, Daum G. Lipids of mitochondria. Prog Lipid Res. 2013; 52(4): 590-614. doi: 10.1016/j.plipres.2013.07.002</mixed-citation><mixed-citation xml:lang="en">Horvath SE, Daum G. Lipids of mitochondria. Prog Lipid Res. 2013; 52(4): 590-614. doi: 10.1016/j.plipres.2013.07.002</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Haines TH. A new look at Cardiolipin. Biochim Biophys Acta. 2009; 1788(10): 1997-2002. doi: 10.1016/j.bbamem.2009.09.008</mixed-citation><mixed-citation xml:lang="en">Haines TH. A new look at Cardiolipin. Biochim Biophys Acta. 2009; 1788(10): 1997-2002. doi: 10.1016/j.bbamem.2009.09.008</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Sathappa M, Alder NN. The ionization properties of cardiolipin and its variants in model bilayers. Biochim Biophys Acta. 2016; 1858(6): 1362-1372. doi: 10.1016/j.bbamem.2016.03.007</mixed-citation><mixed-citation xml:lang="en">Sathappa M, Alder NN. The ionization properties of cardiolipin and its variants in model bilayers. Biochim Biophys Acta. 2016; 1858(6): 1362-1372. doi: 10.1016/j.bbamem.2016.03.007</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci. 2008; 65(16): 2493-2506. doi: 10.1007/s00018-008-8030-5</mixed-citation><mixed-citation xml:lang="en">Houtkooper RH, Vaz FM. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol Life Sci. 2008; 65(16): 2493-2506. doi: 10.1007/s00018-008-8030-5</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis RN, McElhaney RN. The physicochemical properties of cardiolipin bilayers and cardiolipin-containing lipid membranes. Biochim Biophys Acta. 2009; 1788(10): 2069-2079. doi: 10.1016/j.bbamem.2009.03.014</mixed-citation><mixed-citation xml:lang="en">Lewis RN, McElhaney RN. The physicochemical properties of cardiolipin bilayers and cardiolipin-containing lipid membranes. Biochim Biophys Acta. 2009; 1788(10): 2069-2079. doi: 10.1016/j.bbamem.2009.03.014</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Beyer K, Klingenberg M. ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance. Biochemistry. 1985; 24(15): 3821-3826. doi: 10.1021/bi00336a001</mixed-citation><mixed-citation xml:lang="en">Beyer K, Klingenberg M. ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance. Biochemistry. 1985; 24(15): 3821-3826. doi: 10.1021/bi00336a001</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Van Meer G, de Kroon AI. Lipid map of the mammalian cell. J Cell Sci. 2011; 124(1): 5-8. doi: 10.1242/jcs.071233</mixed-citation><mixed-citation xml:lang="en">van Meer G, de Kroon AI. Lipid map of the mammalian cell. J Cell Sci. 2011; 124(1): 5-8. doi: 10.1242/jcs.071233</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HJ, Mayette J, Rapoport SI, Bazinet RP. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis. 2006; 5(1): 2. doi: 10.1186/1476-511X-5-2</mixed-citation><mixed-citation xml:lang="en">Lee HJ, Mayette J, Rapoport SI, Bazinet RP. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis. 2006; 5(1): 2. doi: 10.1186/1476-511X-5-2</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry. 2007; 46(21): 6417-6428. doi: 10.1021/bi7004015</mixed-citation><mixed-citation xml:lang="en">Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. Biochemistry. 2007; 46(21): 6417-6428. doi: 10.1021/bi7004015</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ, 2nd. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J Biol Chem. 1996, 271(38): 23185-23190. doi: 10.1074/jbc.271.38.23185</mixed-citation><mixed-citation xml:lang="en">Morrow JD, Awad JA, Wu A, Zackert WE, Daniel VC, Roberts LJ, 2nd. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. J Biol Chem. 1996, 271(38): 23185-23190. doi: 10.1074/jbc.271.38.23185</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998; 273(22): 13605-13612. doi: 10.1074/jbc.273.22.13605</mixed-citation><mixed-citation xml:lang="en">Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998; 273(22): 13605-13612. doi: 10.1074/jbc.273.22.13605</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Wittig I, Schägger H. Supramolecular organization of ATP synthase and respiratory chain in mitochondrial membranes. Biophys Biochim Acta. 2009; 1787(6): 672-680. doi: 10.1016/j.bbabio.2008.12.016</mixed-citation><mixed-citation xml:lang="en">Wittig I, Schägger H. Supramolecular organization of ATP synthase and respiratory chain in mitochondrial membranes. Biophys Biochim Acta. 2009; 1787(6): 672-680. doi: 10.1016/j.bbabio.2008.12.016</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Bultema JB, Braun HP, Boekema EJ, Kouril R. Megacomplex organization of the oxidative phosphorylation system by structural analysis of respiratory chain supercomplexes from tomato. Biochim Biophys Acta. 2009; 1787(1): 60-67. doi: 10.1016/j.bbabio.2008.10.010</mixed-citation><mixed-citation xml:lang="en">Bultema JB, Braun HP, Boekema EJ, Kouril R. Megacomplex organization of the oxidative phosphorylation system by structural analysis of respiratory chain supercomplexes from tomato. Biochim Biophys Acta. 2009; 1787(1): 60-67. doi: 10.1016/j.bbabio.2008.10.010</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Petersen MW, Skovenborg EL, Rask CU, Hoeg MD, Ornbol E, Schroder A. Physical comorbidity in patients with multiple functional somatic syndromes. A register-based case-control study. J Psychosom Res. 2018; 104: 22-28. doi: 10.1016/j.jpsychores.2017.11.005</mixed-citation><mixed-citation xml:lang="en">Petersen MW, Skovenborg EL, Rask CU, Hoeg MD, Ornbol E, Schroder A. Physical comorbidity in patients with multiple functional somatic syndromes. A register-based case-control study. J Psychosom Res. 2018; 104: 22-28. doi: 10.1016/j.jpsychores.2017.11.005</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1988; 273(22): 13605-13612. doi: 10.1074/jbc.273.22.13605</mixed-citation><mixed-citation xml:lang="en">Roberts LJ, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1988; 273(22): 13605-13612. doi: 10.1074/jbc.273.22.13605</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ. Noncyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 1992; 89(22): 10721-10725. doi: 10.1073/pnas.89.22.10721</mixed-citation><mixed-citation xml:lang="en">Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ. Noncyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 1992; 89(22): 10721-10725. doi: 10.1073/pnas.89.22.10721</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Brame CJ, Boutaud O, Davies SS, Yang T, Oates JA, Roden D, et al. Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem. 2004; 279(14): 13447-13451. doi: 10.1074/jbc.M313349200</mixed-citation><mixed-citation xml:lang="en">Brame CJ, Boutaud O, Davies SS, Yang T, Oates JA, Roden D, et al. Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem. 2004; 279(14): 13447-13451. doi: 10.1074/jbc.M313349200</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Musiek ES, Yin H, Milne GL, Morrow JD. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids. 2005; 40(10): 987-994. doi: 10.1007/s11745-005-1460-7</mixed-citation><mixed-citation xml:lang="en">Musiek ES, Yin H, Milne GL, Morrow JD. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids. 2005; 40(10): 987-994. doi: 10.1007/s11745-005-1460-7</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Montine TJ, Morrow JD. Fatty acid oxidation in the pathogenesis of Alzheimer’s disease. Am J Pathol. 2005; 166(5): 1283-1285. doi: 10.1016/S0002-9440(10)62347-4</mixed-citation><mixed-citation xml:lang="en">Montine TJ, Morrow JD. Fatty acid oxidation in the pathogenesis of Alzheimer’s disease. Am J Pathol. 2005; 166(5): 1283-1285. doi: 10.1016/S0002-9440(10)62347-4</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004; 18(15): 1791-1800. doi: 10.1096/fj.04-2330rev</mixed-citation><mixed-citation xml:lang="en">Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004; 18(15): 1791-1800. doi: 10.1096/fj.04-2330rev</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Davies SS, Roberts LJ. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Rad Biol Med. 2011; 50(5): 559-566. doi: 10.1016/j.freeradbiomed.2010.11.023</mixed-citation><mixed-citation xml:lang="en">Davies SS, Roberts LJ. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Rad Biol Med. 2011; 50(5): 559-566. doi: 10.1016/j.freeradbiomed.2010.11.023</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Panov A. Perhydroxyl radical (HO2•) as inducer of the isoprostane lipid peroxidation in mitochondria. Mol Biol. 2018; 52: 295-305. doi: 10.1134/S0026893318020097</mixed-citation><mixed-citation xml:lang="en">Panov A.Perhydroxyl radical(HO2•)asinducerofthe isoprostane lipid peroxidation in mitochondria. Mol Biol. 2018; 52: 295-305. doi: 10.1134/S0026893318020097</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Panov AV, Dikalov SI. Cardiolipin, perhydroxyl radicals and lipid peroxidation in mitochondrial dysfunctions and aging. Oxidative medicine and cellular longevity. Forthcoming 2020.</mixed-citation><mixed-citation xml:lang="en">Panov AV, Dikalov SI. Cardiolipin, perhydroxyl radicals and lipid peroxidation in mitochondrial dysfunctions and aging. Oxidative medicine and cellular longevity. Forthcoming 2020.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Bielski BH, Arudi RL, Sutherland MW. A study of the reactivity of HO2/O2- with unsaturated fatty acids. J Biol Chem. 1983; 258(8): 4759-4761.</mixed-citation><mixed-citation xml:lang="en">Bielski BH, Arudi RL, Sutherland MW. A study of the reactivity of HO2/O2- with unsaturated fatty acids. J Biol Chem. 1983; 258(8): 4759-4761.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Gebicki JM, Bielski BHJ. Comparison of the capacities of the perhydroxyl and the superoxide radicals to initiate chain oxidation of linoleic acid. J Am Chem Soc. 1981; 103: 7020-7022. doi: 10.1021/ja00413a066</mixed-citation><mixed-citation xml:lang="en">Gebicki JM, Bielski BHJ. Comparison of the capacities of the perhydroxyl and the superoxide radicals to initiate chain oxidation of linoleic acid. J Am Chem Soc. 1981; 103: 7020-7022. doi: 10.1021/ja00413a066</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">De Grey ADNJ. HO2• the forgotten radical. DNA Cell Biology. 2002; 21(4): 251-257. doi: 10.1089/104454902753759672</mixed-citation><mixed-citation xml:lang="en">De Grey ADNJ.HO2•theforgottenradical.DNA Cell Biology. 2002; 21(4): 251-257. doi: 10.1089/104454902753759672</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Haines TH, Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett. 2002; 528(1-3): 35-39. doi: 10.1016/S0014-5793(02)03292-1</mixed-citation><mixed-citation xml:lang="en">Haines TH, Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett. 2002; 528(1-3): 35-39. doi: 10.1016/S0014-5793(02)03292-1</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Arnarez C, Marrink SJ, Periole X. Identification of cardiolipin binding sites on cytochrome c oxidase at the entrance of proton channels. Sci Rep. 2013; 3: 1263. doi: 10.1038/srep01263</mixed-citation><mixed-citation xml:lang="en">Arnarez C, Marrink SJ, Periole X. Identification of cardiolipin binding sites on cytochrome c oxidase at the entrance of proton channels. Sci Rep. 2013; 3: 1263. doi: 10.1038/srep01263</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Bielski BHJ. Reevaluation of the spectral and kinetic properties of HO2• and O2• free radicals. Photochem Photobiol. 1978; 28(4-5): 645-649. doi: 10.1111/j.1751-1097.1978.tb06986.x</mixed-citation><mixed-citation xml:lang="en">Bielski BHJ. Reevaluation of the spectral and kinetic properties of HO2• and O2• free radicals. Photochem Photobiol. 1978; 28(4-5): 645-649. doi: 10.1111/j.1751-1097.1978.tb06986.x</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Barja G. The mitochondrial free radical theory of aging. Prog Mol Biol Transl Sci. 2014; 127: 1-27. doi: 10.1016/B978-0-12-394625-6.00001-5</mixed-citation><mixed-citation xml:lang="en">Barja G. The mitochondrial free radical theory of aging. Prog Mol Biol Transl Sci. 2014; 127: 1-27. doi: 10.1016/B978-0-12-394625-6.00001-5</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Lambert AJ, Boysen HM, Buckingham JA, Yang T, Podlutsky A, Austad SN, et al. Low rates of hydrogen peroxide production by isolated heart mitochondria associate with long maximum lifespan in vertebrate homeotherms. Aging Cell. 2007; 6: 607-618. doi: 10.1111/j.1474-9726.2007.00312.x</mixed-citation><mixed-citation xml:lang="en">Lambert AJ, Boysen HM, Buckingham JA, Yang T, Podlutsky A, Austad SN, et al. Low rates of hydrogen peroxide production by isolated heart mitochondria associate with long maximum lifespan in vertebrate homeotherms. Aging Cell. 2007; 6: 607-618. doi: 10.1111/j.1474-9726.2007.00312.x</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Pamplona R, Barja B, Portero-Otin M. Membrane fatty acid unsaturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation? Ann N Y Acad Sci. 2002; 959: 475-490. doi: 10.1111/j.1749-6632.2002.tb02118.x</mixed-citation><mixed-citation xml:lang="en">Pamplona R, Barja B, Portero-Otin M. Membrane fatty acid unsaturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation? Ann N Y Acad Sci. 2002; 959: 475-490. doi: 10.1111/j.1749-6632.2002.tb02118.x</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Naudi A, Jove M, Ayala V, Portero-Otı´n M, Barja G, Pamplona R. Regulation of membrane unsaturation as antioxidant adaptive mechanisms in long-lived animal species. Free Radic Antioxid. 2011; 1(3): 3-12. doi: 10.5530/ax.2011.3.2</mixed-citation><mixed-citation xml:lang="en">Naudi A, Jove M, Ayala V, Portero-Otı´n M, Barja G, Pamplona R. Regulation of membrane unsaturation as antioxidant adaptive mechanisms in long-lived animal species. Free Radic Antioxid. 2011; 1(3): 3-12. doi: 10.5530/ax.2011.3.2</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Panov A. Mitochondrial production of perhydroxyl radical (HO2•) as inducer of aging and related pathologies. J Biochem Biophys. 2017; 1(1): 105.</mixed-citation><mixed-citation xml:lang="en">Panov A. Mitochondrial production of perhydroxyl radical (HO2•) as inducer of aging and related pathologies. J Biochem Biophys. 2017; 1(1): 105.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Lennicke C, Cocheme HM. Redox signaling and ageing insights from Drosophila. Biochem Soc Trans. 2020; 48(2): 367-377. doi: 10.1042/BST20190052</mixed-citation><mixed-citation xml:lang="en">Lennicke C, Cocheme HM. Redox signaling and ageing insights from Drosophila. Biochem Soc Trans. 2020; 48(2): 367-377. doi: 10.1042/BST20190052</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Detienne G, De Haes W, Mergan L, Edwards SL, Temmerman L, Van Bael S. Beyond ROS clearance: Peroxiredoxins in stress signaling and aging. Ageing Res Rev. 2018; 44: 33-48. doi: 10.1016/j.arr.2018.03.005</mixed-citation><mixed-citation xml:lang="en">Detienne G, De Haes W, Mergan L, Edwards SL, Temmerman L, Van Bael S. Beyond ROS clearance: Peroxiredoxins in stress signaling and aging. Ageing Res Rev. 2018; 44: 33-48. doi: 10.1016/j.arr.2018.03.005</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Dikalov SI, Dikalova AE. Crosstalk between bitochondrial hyperacetylation and oxidative stress in vascular dysfunction and hypertension. Antioxid Redox Signal. 2019; 31(10): 710-721. doi: 10.1089/ars.2018.7632</mixed-citation><mixed-citation xml:lang="en">Dikalov SI, Dikalova AE. Crosstalk between bitochondrial hyperacetylation and oxidative stress in vascular dysfunction and hypertension. Antioxid Redox Signal. 2019; 31(10): 710-721. doi: 10.1089/ars.2018.7632</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Harman D. The aging process. Proc Natl Acad Sci USA. 1981; 78(11): 7124-7128. doi: 10.1073/pnas.78.11.7124</mixed-citation><mixed-citation xml:lang="en">Harman D. The aging process. Proc Natl Acad Sci USA. 1981; 78(11): 7124-7128. doi: 10.1073/pnas.78.11.7124</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6): 231-237. doi: 10.1242/dmm.001180</mixed-citation><mixed-citation xml:lang="en">Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6): 231-237. doi: 10.1242/dmm.001180</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Morris CW. Academic press dictionary of science and technology. California, San-Diego: Academic Press, Inc.; 1992.</mixed-citation><mixed-citation xml:lang="en">Morris CW. Academic press dictionary of science and technology. California, San-Diego: Academic Press, Inc.; 1992.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson AP, Luo X, Russell W, Yin YW. Oxidative damage diminishes mitochondrial DNA polymerase replication fidelity. Nucleic Acids Res. 2020; 48(2): 817-829. doi: 10.1093/nar/gkz1018</mixed-citation><mixed-citation xml:lang="en">Anderson AP, Luo X, Russell W, Yin YW. Oxidative damage diminishes mitochondrial DNA polymerase replication fidelity. Nucleic Acids Res. 2020; 48(2): 817-829. doi: 10.1093/nar/gkz1018</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
